1 CURRICULUM VITAE – DANIEL ABRAMOWICZ ... - Oxford Journals

108. BROEDERS N, WISSING M, HAZZAN M, GHISDAL L, HOANG AD, NOEL C,
MASCART F, ABRAMOWICZ D.
Evolution of immunoglobulin and mannose binding protein levels after renal transplantation:
association with infectious complications.
Transplant International 2008 Jan; 21 (1): 57-64.
109. GHISDAL L., BEN BOUCHTA N., BROEDERS N., CRENIER L., HOANG A-D,
ABRAMOWICZ D., WISSING KM.
Conversion from tacrolimus to cyclosporine A for new-onset diabetes after
transplantation: a single-centre experience in renal transplanted patients and review of the
literature.
Transpl Int. 2008 Feb; 21(2): 146-51
110. WISSING KM, FOMEGNÉ G, BROEDERS N, GHISDAL L, HOANG AD,
MIKHALSKI D, DONCKIER V, VEREERSTRAETEN P, ABRAMOWICZ D.
HLA mismatches remain risk factors for acute kidney allograft rejection in patients
receiving quadruple immunosuppression with anti-IL2 receptor antibodies.
Transplantation 2008 Feb 15; 85(3): 411-416.
111. LEMY A, WISSING KM, RORIVE S, ZLOTTA A, ROUMEGUERE T, MUNIZ
MARTINEZ MC, DECAESTECKER C, SALMON I, ABRAMOWICZ D,
VANHERWEGHEM JL, NORTIER J.
Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage
aristolochic acid nephropathy: a case series with 15-year follow-up.
Am J Kidney Dis. 2008 Mar; 51(3):471-7.
112. MIKHALSKI D, WISSING KM, GHISDAL L, BROEDERS N, TOULY M, HOANG
AD, LOI P, MBOTI F, DONCKIER V, VEREERSTRAETEN P, ABRAMOWICZ D.
Cold ischemia is a major determinant of acute rejection and renal graft survival in the
modern era of immunosuppression.
Transplantation 2008 Apr 15;85 (7 Suppl): S3-9
23